U.S. markets closed
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • Dow 30

    32,654.59
    +431.17 (+1.34%)
     
  • Nasdaq

    11,984.52
    +321.73 (+2.76%)
     
  • Russell 2000

    1,840.30
    +56.87 (+3.19%)
     
  • Crude Oil

    112.05
    -2.15 (-1.88%)
     
  • Gold

    1,813.80
    -0.20 (-0.01%)
     
  • Silver

    21.62
    +0.07 (+0.34%)
     
  • EUR/USD

    1.0546
    +0.0108 (+1.03%)
     
  • 10-Yr Bond

    2.9680
    +0.0910 (+3.16%)
     
  • GBP/USD

    1.2484
    +0.0160 (+1.30%)
     
  • USD/JPY

    129.3620
    +0.3090 (+0.24%)
     
  • BTC-USD

    30,104.37
    +436.54 (+1.47%)
     
  • CMC Crypto 200

    675.48
    +432.80 (+178.34%)
     
  • FTSE 100

    7,518.35
    +53.55 (+0.72%)
     
  • Nikkei 225

    26,659.75
    +112.70 (+0.42%)
     

Regional biotech and health firms raked in record investments in 2021

·3 min read
Regional biotech and health firms raked in record investments in 2021
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

All told, there was about $324 million in VC investments in biotech and digital health companies last year, according to data compiled by PitchBook and The Business Journal. Absci Corp., a synthetic biology company based in Vancouver that went public last July, led the pack, with a $125 million investment led by New York-based Casdin Capital and Redmile Group, on the heals of a $65 million deal in October 2020.